NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 21 filers reported holding NABRIVA THERAPEUTICS AG in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $499,000 | – | 52,563 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,145,890 | $10,267,000 | 7.12% |
| Vivo Capital, LLC | 3,151,700 | $28,239,000 | 7.08% |
| ACUTA CAPITAL PARTNERS, LLC | 544,972 | $4,883,000 | 2.73% |
| EcoR1 Capital, LLC | 707,817 | $6,342,000 | 2.22% |
| Boxer Capital, LLC | 176,710 | $1,583,000 | 1.55% |
| Opaleye Management Inc. | 273,800 | $2,453,000 | 1.53% |
| Novo Holdings A/S | 874,985 | $7,840,000 | 0.86% |
| Rock Springs Capital Management LP | 380,000 | $3,405,000 | 0.28% |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 2,382,820 | $21,326,000 | 0.24% |
| FT Options LLC | 23,163 | $208,000 | 0.22% |